Genmab | GEN - Pre Utilidad Fiscal

Precio De Mercado
1,690.00
Cambio Diario
35.00 2.11%
Mensual
-1.34%
Anual
20.80%
Q2 Expectativa
1,628.53




Pre Utilidad Fiscal Cambio Fecha
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Almirall EUR 30.32M 22M 2025-12
Amarin USD -852K 7.26M 2025-12
Amgen USD 3.92B 2.35B 2025-09
argenx SE USD 386.05M 99.15M 2025-09
AstraZeneca USD 3.91B 1.28B 2026-03
Bayer EUR -1.16B 735M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Demant DKK 1.46B 497M 2025-06
Exelixis USD 252.69M 275K 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GN Store Nord DKK 450M 332M 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Insmed USD -326.93M 41.77M 2025-12
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06